These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3362744)

  • 1. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Peptides; 1988; 9(1):203-6. PubMed ID: 3362744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
    Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
    Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new kinin moiety in human plasma kininogens.
    Mindroiu T; Carretero OA; Proud D; Walz D; Scicli AG
    Biochem Biophys Res Commun; 1988 Apr; 152(2):519-26. PubMed ID: 3365237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
    Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
    Gomes RA; Juliano L; Chagas JR; Hial V
    Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
    Hilgenfeldt U; Stannek C; Lukasova M; Schnölzer M; Lewicka S
    Br J Pharmacol; 2005 Dec; 146(7):958-63. PubMed ID: 16231010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides.
    Okunishi H; Spragg J; Burton J; Toda N
    Adv Exp Med Biol; 1989; 247B():23-8. PubMed ID: 2481944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myostimulating effect of tissue kallikrein on rat uterus.
    Damas J; Bourdon V; Pinto JC
    Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):535-41. PubMed ID: 7643918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
    Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
    Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinins contribute to the contractile effects of rat glandular kallikrein on the isolated rat uterus.
    Orce GG; Carretero OA; Scicli G; Scicli AG
    J Pharmacol Exp Ther; 1989 May; 249(2):470-5. PubMed ID: 2724135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of [hydroxyproline3]Lysyl-bradykinin formed by kallikrein from human plasma protein.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Adv Exp Med Biol; 1989; 247A():539-44. PubMed ID: 2603820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.
    Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR
    Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo assay of specific kallikrein inhibitors.
    Okunishi H; Spragg J; Burton J
    Agents Actions Suppl; 1987; 22():381-90. PubMed ID: 3481213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of [hydroxyproline3]-lysyl-bradykinin released from human plasma protein by kallikrein.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Biochem Biophys Res Commun; 1988 Jan; 150(1):511-6. PubMed ID: 3337729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.